You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

6 Results
Guidelines and Advice
Status: Archived
ID: 7-15
Version: 2
Jan 2014
Guidelines and Advice
Status: Current
ID: PET ES-15
Jan 2014
Guidelines and Advice
Status: Current
ID: PET ES-14
Jan 2014
Drug
Other Name(s): Trelstar® (Allergan Pharma)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Oct 2014
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2022
Guidelines and Advice
Status: In-Review
ID: 8-8
Aug 2014